Jpmorgan Chase & CO Illumina, Inc. Transaction History
Jpmorgan Chase & CO
- $1.14 Trillion
- Q2 2024
A detailed history of Jpmorgan Chase & CO transactions in Illumina, Inc. stock. As of the latest transaction made, Jpmorgan Chase & CO holds 635,403 shares of ILMN stock, worth $97.5 Million. This represents 0.01% of its overall portfolio holdings.
Number of Shares
635,403
Previous 1,134,678
44.0%
Holding current value
$97.5 Million
Previous $156 Million
57.43%
% of portfolio
0.01%
Previous 0.01%
Shares
13 transactions
Others Institutions Holding ILMN
# of Institutions
879Shares Held
139MCall Options Held
1.42MPut Options Held
1.61M-
Black Rock Inc. New York, NY18.1MShares$2.77 Billion0.04% of portfolio
-
Vanguard Group Inc Valley Forge, PA15.9MShares$2.44 Billion0.03% of portfolio
-
State Street Corp Boston, MA5.6MShares$859 Million0.03% of portfolio
-
Loomis Sayles & CO L P4.46MShares$685 Million0.64% of portfolio
-
Baillie Gifford & CO3.62MShares$556 Million0.36% of portfolio
About ILLUMINA, INC.
- Ticker ILMN
- Exchange NASDAQ
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 157,300,000
- Market Cap $24.1B
- Description
- Illumina, Inc. provides sequencing and array-based solutions for genetic and genomic analysis. Its products and services serve customers in a range of markets enabling the adoption of genomic solutions in research and clinical settings for applications in the life sciences, oncology, reproductive health, agriculture, and other emerging segments....